MarketPulse
H

$HUMA

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Humacyte, Inc.

Humacyte Bolsters Leadership With Renowned Vascular Surgeon as Chief Surgical Officer

Humacyte appoints Mayo Clinic vascular surgeon Dr. Todd Rasmussen as Chief Surgical Officer to advance clinical adoption of bioengineered tissue product Symvess.
HUMAHUMAWFDA approvalclinical adoption
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Humacyte Posts $2M Revenue as Biotech Pushes Toward FDA Approval Milestone

Biotech firm Humacyte reported $2M in 2025 revenues from 61 Symvess unit sales, secured Saudi Arabia commitment, and targets critical Phase 3 results in Q2 2026.
HUMAHUMAWPhase 3 clinical trialFDA approval